CGEM — CULLINAN THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in CULLINAN THERAPEUTICS INC (CGEM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2025 Q2)
Avg. % of fund
0.01%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 5,800 -22,589 -79.6% 0.00% $60K $10.35
2025 Q3 REDUCED 28,389 -147,038 -83.8% 0.00% $168K $5.93
2025 Q2 REDUCED 175,427 -406,673 -69.9% 0.01% $1.3M $7.53
2025 Q2 ADDED 582,100 +559,100 +2430.9% 0.05% $4.4M $7.53
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CGEM price (monthly, adj. close)

Other funds also holding CGEM

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 18.78% MPM BioImpact LLC 3Y 9.06% GREAT POINT PARTNERS LLC 3Y 7Y 2.13% Kynam Capital Management, LP 3Y 2.06% BVF INC/IL 3Y 7Y 2.0% Blue Owl Capital Holdings LP 3Y 1.82% Affinity Asset Advisors, LLC 3Y 1.14% Elmind Capital, LP 0.95% TWIN FOCUS CAPITAL PARTNERS, LLC 3Y 7Y 0.71% VR Adviser, LLC 3Y 0.71%
← Back to Caption Management, LLC Holdings